Data for Defining Fibrinogen and Its Plasmic Degradation Products

• References

• 1 Alkjaersig N, Fletcher A. P, Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states II. The significance, mechanism and consequences of defective fibrin polymerization.. Journal of Clinical Investigation 1962; 41: 917
• 2 Blombäck B, Vestermark A. Studies on fibrinopeptides. Arkiv Kemi 1958; 12: 173
• 3 Blombäck B, Blombäck M, Edman P, Hessel B. Human fibrinopeptides Isolation, characterization and structure. Biochimica et Biophysica Acta 1966; 115: 371
• 4 Blombäck B, Blombäck M, Henschen A, Hessel B, Iwanaga S, Woods K. R. N-terminal disulfide knot of human fibrinogen. Nature 1968; 218: 130
• 5 Blombäck B. Selectional trends in the structure of fibrinogen of different species. Symposium of the Zoological Society of London 1910; 27: 167
• 6 Blombäck B, Johnson A. J. Joint report of the subcommittees of nomenclature and on fibrinolysis, thrombolysis and intravascular coagulation. Thrombosis et Diathesis Haemorrhagica Suppl. 51 1971; 251
• 7 Blombäck B. Report of the subcommittee on nomenclature. Thrombosis et Diathesis Haemorrhagica Suppl. 54 1973; 425
• 8 Budzynski A. Z. Structure of fibrinogen in relation to its proteolytic degradation products. Postępy Higieny in Medycyny Dóswiadczalnej 1969; 23: 293
• 9 Budzynski A. Z, Stahl M, Kopeć M, Latallo Z. S, Wegrzynowicz Z, Kowalski E. High molecular weight products of the late stage of fibrinogen proteolysis by plasmin and their structural relation to the fibrinogen molecule. Biochimica et Biophysica Acta 147 1967; 313
• 10 Budzynski A. Z, Marder V. J, Shainoff J. R. Structure of plasmic degradation products of human fibrinogen. Fibrinopeptide and polypeptide chain analysis. Journal of Biological Chemistry 1974; 249: 2294
• 11 Caspary E. A, Kekwick R. A. Some physicochemical properties of human fibrinogen. Biochemical Journal 1957; 67: 41
• 12 Chen R, Doolittle R. F. γ-γ cross-linking sites in human and bovine fibrin. Biochemistry 10 1971; 4486
• 13 Collen et al. 1975
• 14 Donnelly T. H, Laskowski jr. M, Notley N, Scheraga H. A. Equilibria in the fibrinogen — fibrin conversion II. Reversibility of the polymerization steps. Archives of Biochemistry and Biophysics 1956; 56: 369
• 15 Dudek G. A, Kloczewiak M, Budzynski A. Z, Latallo Z. S, Kopeć M. Characterization and comparison of macromolecular end products of fibrinogen and fibrin proteolysis by plasmin. Biochimica et Biophysica Acta 1970; 214: 44
• 16 Endres G. F, Scheraga H. A. Molecular weight of bovine fibrinogen by sedimentation equilibrium. Archives of Biochemistry and Biophysics 1971; 144: 519
• 17 Fletcher A. P, Alkjaersig N, Fisher S, Sherry S. The proteolysis of fibrinogen by plasmin: the identification of thrombinclottable fibrinogen derivatives which polymerize abnormally. Journal of Laboratory and Clinical Medicine 1966; 68: 780
• 18 Furlan M, Beck E. A. Plasmic degradation of human fibrinogen I. Structural characterization of degradation products. Biochimica et Biophysica Acta 263 1972; 631
• 19 Furlan M, Beck E. A. Plasmic degradation of human fibrinogen II. Further characterization of Fragment D. Biochimica et Biophysica Acta 310 1973; 205
• 20 Furlan M, Kemp G, Beck E. A. The covalent structure of Fragment D from human fibrinogen. Biochimica et Biophysica Acta, in press 1975
• 21 Gaffney P. J, Brasher M. Subunit structure of the plasmininduced degradation products of crosslinked fibrin. Biochimica et Biophysica Acta 295 1973; 308
• 22 Gaffney P. J, Dobos P. A structural aspect of human fibrinogen suggested by its plasmin degradation. FEBS letters 1971; 15: 13
• 23 GÅrdlund B, Kowalska-Loth B, Gröndahl N. J, Blombäck B. Plasmic degradation products of human fibrinogen I. Isolation and characterization of Fragments E and D and their relation to “Disulfide knots.”. Thrombosis Research 1972; 1: 371
• 24 Gladner J. A, Folk J. E, Laki K, Carroll W. R. Thrombin-induced formation of co-fibrin I. Isolation, purification, and characterization of co-fibrin.. Journal of Biological Chemistry 1959; 234: 62
• 25 Kierulf P. N-terminal analysis of “fibrins” from plasmin hydrolysed fibrinogenevidence for lack of fibrinopeptide B. Thrombosis Research 1972; 1: 527
• 26 Kopeć M, Teisseyre E, Dudek-Wojciechowska G, Kloczewiak M, Pankiewicz A, Latallo Z. S. Studies on the “Double D” fragment from stabilized bovine fibrin. Thrombosis Research 1973; 2: 283
• 27 Kowalska-Loth B, GÅrdlund B, Egberg N, Blombäck B. Plasmic degradation products of human fibrinogen I. Chemical and immunological relation between Fragment E and N-DSK.. Thrombosis Research 1973; 2: 423
• 28 Larrieu M. J, Marder V. J, Inceman S. Effects of fibrinogen degradation products on platelets and coagulation. In: Diffuse Intravascular Clotting. Transaction of the International Committee on Haemostasis and Thrombosis 1965 Stuttgart, F. K.; Schattauer-Verlag: 1966: 215
• 29 Larrieu M. J, Rigollot C, Marder V. J. Comparative effects of fibriogen degradation Fragments D and E on coagulation. British Journal of Haematology 1972; 22: 719
• 30 Latallo Z. S, Fletcher A. P, Alkjaersig N, Sherry S. Inhibition of fibrin polymerization by fibrinogen proteolysis products. American Journal of Physiology 1962; 202: 681
• 31 Latallo Z. S, Budzynski A. Z, Lipinski B, Kowalski E. Inhibition of thrombin and of fibrin polymerization. Two activities derived from plasmindigested fibrinogen. Nature 1964; 203: 1184
• 32 Marder V. J, Shulman N. R, Carroll W. R. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage. Transactions of the Association of American Physicians 1967; 53: 156
• 33 Marder V. J, Shulman N. R, Carroll W. R. High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. Journal of Biological Chemistry 1969; a 244: 2111
• 34 Marder V. J, Shulman N. R. High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity. Journal of Biological Chemistry 1969; b 244: 2120
• 35 Marder V. J, Budzynski A. Z. Classification of fibrinogen derivatives. Thrombosis et Diathesis Haemorrhagica supplement 1971; a 51: 267
• 36 Marder V. J. Fibrinogen and fibrin degradation products. Physicochemical and physiological considerations. Thrombosis et Diathesis Haemorrhagica Suppl. 85 47 1971; b
• 37 Marder V. J. Identification and purification of fibrinogen degradation products produced by plasmin. Considerations on the structure of fibrinogen In: Verstraete M, Vermylen J, Donati M. B. (Eds.) Fibrinogen Degradation Products. International Workshop, Leuven, Belgium. Scandinavica Haematologica supplement 1971; 13: 21
• 38 Marder V. J, Budzynski A. Z, James H. L. High molecular weight derivatives of human fibrinogen produced by plasmin III. Their NH₂-terminal amino acids and comparison with the “NH₂-terminal disulfide knot.”. Journal of Biological Chemistry 1972; 247: 4775
• 39 Marguerie 1975
• 40 Mills D, Karpatkin S. Heterogeneity of human fibrinogen: Possible relation to proteolysis by thrombin and plasmin as studied by SDS-Polyacrylamide gel electrophoresis. Biochemical and Biophysical Research Communication 1970; 40: 206
• 41 Mills D, Karpatkin S. The initial macromolecular derivatives of human fibrinogen produced by plasmin. Biochimica Biophysica Acta 1972; 271: 163
• 42 Mills D. A. Molecular mode for the proteolysis of human fibrinogen by plasmin. Biochimica et Biophysica Acta 1972; 263: 619
• 43 Mosesson M. W, Alkjaersig N, Sweet B, Sherry S. Human fibrinogen of relatively high solubility. Comparative biophysical, biochemical, and biological studies with fibrinogen of lower solubility. Biochemistry 1967; 6: 3279
• 44 Mosesson M. W, Umfleet R. A. The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components. Journal of Biological Chemistry 1970; 245: 5728
• 45 Mosesson M. W, Finlayson J. S, Umfleet R. A. Human Fibrinogen Heterogeneities. III. Identification of γ-chain variants.. Journal of Biological Chemistry 1972; 247: 5223
• 46 Mosesson M. W, Finlayson J. S, Galankis D. K. The essential covalent structure of human fibrinogen envinced by analysis of derivatives formed during plasmic hydrolysis. Journal of Biological Chemistry 1973; 249: 7913
• 47 McKee P. A, Rogers L. A, Marler E, Hill R. L. The subunit polypeptides of human fibrinogen. Archives of Biochemistry and Biophysics 1966; 116: 271
• 48 Niléhn J. E. Split products of fibrinogen after prolonged interaction with plasmin. Thrombosis et Diathesis Haemorrhagica 1967; 18: 89
• 49 Nussenzweig V, Seligmann M, Pelmont U, Grabar P. Les produits de dégradation du fibrinogène humain par la plasmine. I. Séparation et propriétés physico-chimiques.. Ann. Inst. Pasteur 1961; a 100: 377
• 50 Nussenzweig V, Seligmann M, Grabar P. Les produits de dégradation du fibrinogène humain par la plasmine. II. Etude immunologique : Mise en évidence d’anticorps antifibrinogène natif possédant des spécificites différentes. Ann. Inst. Pasteur 1961; b 100: 490
• 51 Okude M, Iwanaga S. Carboxy-terminal residues of mammalian fibrinogen and fibrin. Biochimica et Biophysica Acta 1971; 251: 185
• 52 Pizzo S. V, Schwartz M. L, Hill R. L, McKee P. A. The effect of plasmin on the subunit structure of human fibrinogen. Journal of Biological Chemistry 1972; 247: 636
• 53 Pizzo S. V, Schwartz M. L, Hill R. L, McKee P. A. The effect of plasmin on the subunit structure of human fibrin. Journal of Biological Chemistry 1973; a 248: 4574
• 54 Pizzo S. V, Taylor Jr. L. M, Schwartz M. L, Hill R. L, McKee P. A. Subunit structure of fragment D from fibrinogen and cross-linked fibrin. Journal of Biological Chemistry 248 1973; b 4584
• 55 Shulman S. The size and shape of bovine fibrinogen. Studies of sedimentation diffusion and viscosity. Journal of the American Chemistry Society 1953; 75: 5846
• 56 Triantaphyllopoulos D. C, Triantaphyllopoulos E. Evidence of antithrombotic activity of the anticoagulant fraction of incubated fibrinogen. British Journal of Haematology 1966; 12: 145